Tech Company Financing Transactions
Pandion Therapeutics Funding Round
JDRF T1D Fund participated in a venture round for Pandion Therapeutics. The round closed on 12/20/2018.
Transaction Overview
Company Name
Announced On
12/20/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
JDRF T1D Fund (Jonathan Behr)
Proceeds Purpose
This financing will enable the company to launch a type 1 diabetes (T1D)-focused program leveraging its innovative technology platform and pipeline.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
610 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rahul Kakkar
Chief Operating Officer
Ed Freedman
Chief Scientific Officer
Jo Viney
VP - Bus. Development
Vikas Goyal
VP - Engineering
Hussam Shaheen
Browse more venture capital transactions:
Prev: 12/20/2018: Kindur venture capital transaction
Next: 12/20/2018: Prometheum venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs